DeFinium Therapeutics Inc (DFTX)

Jun 26, 2026, 9:30 AM EDT - 2 days ago

A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year

CMPS

Jun 25, 2026, 4:15 PM EDT - 3 days ago

Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Jun 25, 2026, 11:31 AM EDT - 3 days ago

Biotech ETF Index Surges 10% After Rebalance

ALKS APGE DYN KLRA KYMR MANE MIRM

2026-06-24T16:05:36.000Z - 4 days ago

Definium Therapeutics rises 21.8%

2026-06-24T15:25:15.000Z - 4 days ago

Definium Therapeutics Stock (DFTX) Soars on a Public Offering Pricing After Strong Trial Results

BAC JEF JPM

2026-06-24T14:05:51.000Z - 4 days ago

Definium Therapeutics rises 17.7%

2026-06-24T10:20:19.000Z - 5 days ago

Definium Therapeutics 20.6M share Secondary priced at $34.00

2026-06-24T08:40:13.000Z - 5 days ago

Definium Therapeutics price target raised to $74 from $61 at JonesResearch

Jun 23, 2026, 9:57 PM EDT - 5 days ago

Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering

2026-06-23T10:50:11.000Z - 6 days ago

Definium Therapeutics price target raised to $57 from $37 at Baird

2026-06-22T20:18:37.000Z - 6 days ago

Definium Therapeutics offers to sell $500M in common stock

Jun 22, 2026, 4:01 PM EDT - 6 days ago

Definium Therapeutics, Inc. Announces Proposed Public Offering

2026-06-22T18:05:07.000Z - 6 days ago

Canaccord ups Definium Therapeutics target to $60, calls DT120 ‘solid contender’

2026-06-22T17:35:07.000Z - 6 days ago

Definium Therapeutics price target raised to $60 from $38 at Canaccord

2026-06-22T16:11:28.000Z - 6 days ago

Definium Therapeutics rises 55.9%

2026-06-22T15:41:55.000Z - 6 days ago

Definium Therapeutics price target raised to $60 from $40 at Oppenheimer

2026-06-22T15:35:07.000Z - 6 days ago

Definium Therapeutics price target raised to $57 from $36 at RBC Capital

2026-06-22T14:22:00.000Z - 6 days ago

Definium Therapeutics Stock (DFTX) Rockets on a Phase 3 Trial Win

2026-06-22T14:13:42.000Z - 6 days ago

Definium can climb 50%-100% after ‘robust’ MDD data, says Jefferies

2026-06-22T14:12:05.000Z - 6 days ago

Definium Therapeutics rises 55.7%

2026-06-22T13:56:30.000Z - 6 days ago

RBC Capital says would buy Definium Therapeutics after Phase III data

2026-06-22T13:53:07.000Z - 6 days ago

Definium Therapeutics DT120 data exceeds expectations, says Stifel

Jun 22, 2026, 8:00 AM EDT - 7 days ago

Definium Therapeutics Transcript: Study result

Jun 22, 2026, 8:00 AM EDT - 7 days ago

Definium Therapeutics Press release: Study result

Jun 22, 2026, 8:00 AM EDT - 7 days ago

Definium Therapeutics Slides: Study result

Jun 22, 2026, 7:00 AM EDT - 7 days ago

Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

Jun 22, 2026, 7:00 AM EDT - 7 days ago

Definium Therapeutics Slides: Corporate presentation

Jun 21, 2026, 5:00 PM EDT - 7 days ago

Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026

Jun 15, 2026, 4:01 PM EDT - 13 days ago

Definium Therapeutics Announces New Employee Inducement Grants

Jun 11, 2026, 10:00 AM EDT - 17 days ago

Definium Therapeutics Transcript: AGM 2026

Jun 3, 2026, 3:10 PM EDT - 25 days ago

Definium Therapeutics Transcript: Jefferies Global Healthcare Conference 2026

May 21, 2026, 7:00 AM EDT - 5 weeks ago

Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

May 19, 2026, 8:00 AM EDT - 5 weeks ago

Definium Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 12, 2026, 7:00 AM EDT - 6 weeks ago

Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Definium Therapeutics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Definium Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Definium Therapeutics Quarterly report: Q1 2026

May 7, 2026, 4:01 PM EDT - 7 weeks ago

Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

May 7, 2026, 4:00 PM EDT - 7 weeks ago

Definium Therapeutics Slides: Corporate presentation

Apr 30, 2026, 4:01 PM EDT - 2 months ago

Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Proxy statement: Proxy filing

Apr 22, 2026, 4:15 PM EDT - 2 months ago

Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

Apr 22, 2026, 10:00 AM EDT - 2 months ago

Definium Therapeutics Transcript: Investor Day 2026

Apr 22, 2026, 10:00 AM EDT - 2 months ago

Definium Therapeutics Slides: FY 2026

Apr 20, 2026, 2:05 PM EDT - 2 months ago

How Trump's psychedelics executive order could unlock stalled cannabis reform

ATAI CMPS HELP GHRS

Apr 20, 2026, 10:45 AM EDT - 2 months ago

Psychedelic Stocks Surge After Trump Signs Order Fast-Tracking Drug Research

ATAI CMPS GHRS

Apr 20, 2026, 8:26 AM EDT - 2 months ago

Psychedelic stocks rally with Trump's support

ATAI CMPS GHRS

Apr 20, 2026, 8:18 AM EDT - 2 months ago

Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring.

ATAI CMPS GHRS

Apr 20, 2026, 6:43 AM EDT - 2 months ago

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

ATAI CMPS ENVB GHRS HELP

Apr 18, 2026, 7:38 PM EDT - 2 months ago

Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments

Apr 16, 2026, 3:00 PM EDT - 2 months ago

Definium Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 9, 2026, 7:00 AM EDT - 2 months ago

Definium Therapeutics to Participate at Upcoming Investor Conferences and Events

Mar 31, 2026, 7:00 AM EDT - 3 months ago

New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States

Mar 26, 2026, 7:00 AM EDT - 3 months ago

Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026

Mar 17, 2026, 3:30 PM EDT - 3 months ago

Definium Therapeutics Transcript: Stifel 2026 Virtual CNS Forum

Mar 11, 2026, 1:00 PM EDT - 3 months ago

Definium Therapeutics Transcript: Leerink Global Healthcare Conference 2026

Mar 2, 2026, 9:10 AM EST - 4 months ago

Definium Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 9:10 AM EST - 4 months ago

Definium Therapeutics Slides: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 4:30 PM EST - 4 months ago

Definium Therapeutics Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

Definium Therapeutics Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

Definium Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 4:01 PM EST - 4 months ago

Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates

Feb 26, 2026, 4:00 PM EST - 4 months ago

Definium Therapeutics Slides: Corporate presentation

Feb 24, 2026, 7:01 AM EST - 4 months ago

Definium Therapeutics to Participate at Upcoming Investor Conferences

Feb 19, 2026, 4:01 PM EST - 4 months ago

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

Jan 29, 2026, 7:00 AM EST - 5 months ago

Definium Therapeutics Appoints Roger Adsett to Board of Directors

Jan 20, 2026, 7:00 AM EST - 5 months ago

Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care

Jan 14, 2026, 5:15 PM EST - 5 months ago

Definium Therapeutics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 7:00 AM EST - 5 months ago

Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol “DFTX” Effective January 15, 2026

Jan 12, 2026, 2:45 PM EST - 5 months ago

Definium Therapeutics Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 6 months ago

MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026

Dec 18, 2025, 7:01 AM EST - 6 months ago

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 4:01 PM EST - 6 months ago

MindMed Announces New Employee Inducement Grant

Dec 3, 2025, 3:00 PM EST - 7 months ago

Definium Therapeutics Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 12:30 PM EST - 7 months ago

Definium Therapeutics Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 1, 2025, 4:01 PM EST - 7 months ago

MindMed Announces New Employee Inducement Grants

Nov 18, 2025, 7:00 AM EST - 7 months ago

Definium Therapeutics Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 1:20 PM EST - 8 months ago

Definium Therapeutics Transcript: Stifel 2025 Healthcare Conference

Nov 9, 2025, 6:00 PM EST - 8 months ago

Definium Therapeutics Slides: Corporate Presentation

Nov 6, 2025, 4:30 PM EST - 8 months ago

Definium Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Definium Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Definium Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:01 PM EST - 8 months ago

MindMed Reports Q3 2025 Financial Results and Business Updates

Nov 6, 2025, 7:00 AM EST - 8 months ago

Definium Therapeutics Slides: Corporate Presentation

Nov 5, 2025, 7:01 AM EST - 8 months ago

MindMed to Participate in Upcoming Investor Conferences

Nov 3, 2025, 7:01 AM EST - 8 months ago

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Oct 30, 2025, 4:01 PM EDT - 8 months ago

MindMed to Report Q3 2025 Financial Results on November 6, 2025

Oct 29, 2025, 10:14 PM EDT - 8 months ago

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering

Oct 29, 2025, 4:01 PM EDT - 8 months ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Sep 19, 2025, 7:00 AM EDT - 10 months ago

New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)

Sep 18, 2025, 1:00 PM EDT - 10 months ago

Definium Therapeutics Transcript: TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Sep 9, 2025, 3:30 PM EDT - 10 months ago

Definium Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 11:05 AM EDT - 10 months ago

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)

Aug 28, 2025, 7:00 AM EDT - 10 months ago

MindMed to Participate in September Investor Conferences

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Quarterly report: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Earnings release: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Slides: Q2 2025

Jul 31, 2025, 4:01 PM EDT - 11 months ago

MindMed Reports Q2 2025 Financial Results and Business Updates

Jul 24, 2025, 7:00 AM EDT - 1 year ago

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025

Jun 17, 2025, 7:00 AM EDT - 1 year ago

Definium Therapeutics Transcript: H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 12, 2025, 10:00 AM EDT - 1 year ago

Definium Therapeutics Transcript: AGM 2025

Jun 5, 2025, 12:50 PM EDT - 1 year ago

Definium Therapeutics Transcript: Jefferies Global Healthcare Conference 2025

May 28, 2025, 7:00 AM EDT - 1 year ago

MindMed to Participate in June Investor Conferences

May 27, 2025, 7:00 AM EDT - 1 year ago

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

May 21, 2025, 2:05 PM EDT - 1 year ago

Definium Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 13, 2025, 7:00 AM EDT - 1 year ago

MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Slides: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates

Apr 24, 2025, 7:00 AM EDT - 1 year ago

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Proxy statement: Proxy Filing

Apr 15, 2025, 7:00 AM EDT - 1 year ago

MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

Mar 17, 2025, 7:00 AM EDT - 1 year ago

MindMed Appoints Matt Wiley as Chief Commercial Officer